Cargando…
Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation
Background: The 2016 World Health Organization (WHO) consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, recommended to start all HIV-infected children on antiretroviral therapy (ART). Here, we explore the possible benefits and risks of implementing...
Autores principales: | Barlow-Mosha, Linda, Musiime, Victor, Davies, Mary-Ann, Prendergast, Andrew J., Musoke, Philippa, Siberry, George, Penazzato, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527851/ https://www.ncbi.nlm.nih.gov/pubmed/28691434 http://dx.doi.org/10.7448/IAS.20.1.21552 |
Ejemplares similares
-
Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies
por: Penazzato, Martina, et al.
Publicado: (2023) -
Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study
por: Musoke , Philippa M, et al.
Publicado: (2010) -
Treatment of Young Children with HIV Infection: Using Evidence to Inform Policymakers
por: Prendergast, Andrew J., et al.
Publicado: (2012) -
Metabolic complications and treatment of perinatally HIV-infected children and adolescents
por: Barlow-Mosha, Linda, et al.
Publicado: (2013) -
Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy
por: Crook, Angela M., et al.
Publicado: (2016)